|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03869 HOSPITAL CORP
Nominal 
3.400 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 732,772 | -1.382% | 1,471,013 | 1,442,292 | 1,427,733 | 1,142,951 |
| Cost of Sales | (555,397) | -6.811% | (1,203,394) | (1,166,473) | (1,188,373) | (992,073) |
| Gross Profit | 177,375 | 20.621% | 267,619 | 275,819 | 239,360 | 150,878 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (39,068) | (21) | 884 | (462,150) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 76,483 | -61.995% | 186,593 | 73,808 | 216,204 | (532,628) | |
| Taxation | (33,520) | 2.737% | (47,564) | (47,479) | (47,860) | 4,031 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (27,627) | 85.379% | (2,612) | (52,418) | (36,960) | 47,649 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 15,336 | -90.023% | 136,417 | (26,089) | 131,384 | (480,948) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 48,766 | -- | (65,323) | 108,053 | (88,366) | (5,360) |
| Depreciation & Amortisation | 29,614 | -9.393% | -- | -- | 68,613 | 63,279 |
| Directors' Emoluments | -- | -- | -- | -- | 2,262 | 6,389 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 11.000 | -90.265% | 100.000 | -19.000 | 95.600 | -348.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 1.157 | 1.547 | 0.611 | 1.036 |
| NBV per share ($) | 4.086 | -- | 3.636 | 2.451 | 2.743 | 1.850 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 15,336 |
| %Change | -90.023% |
| EPS / (LPS) | RMB 0.110 |
| NBV Per Share (¥) | RMB 4.086 |